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Abstract
Background: In order to support evidence-based policies for reduction of stigma, a better understanding of its
components: ignorance (knowledge), prejudice (attitude) and discrimination (behaviour) is necessary. This study
explores public perceptions and quantifies stigma for three chronic mental disorders: autism, schizophrenia and
bipolar disorders in France.
Methods: Survey of 1000 adults selected from an established market research panel. The 21-item questionnaire
explored knowledge, attitudes and behaviours toward each disorder.
Results: Although 95% respondents recognized the names of each disorder fewer than 70% could report specific
characteristics and only 33% considered that publically available information was adequate; most respondents
identified the media as their main resource. Labeling of conditions in a negative way was frequent (61%) when
referring to mental disorders in general, but fell significantly (18%) when linked to an individual with a disorder.
Individuals with schizophrenia are assumed to be dangerous; 65% respondents would engage in social distancing
from such an individual, versus 29% for bipolar disorders and 7% for autism (p < 0.001). In contrast to other
disorders, discrimination against schizophrenia was only partly attenuated in those with familiarity with mental
disorders (through personal or family illness).
Conclusion: This first population-based survey in France shows that attitudes towards bipolar disorders and autism
are less prejudicial than towards schizophrenia. However, most public attitudes and behaviours towards different
disorders appear to be based on assumptions rather than knowledge or evidence suggesting a generic information
or anti-stigma programme is unlikely to be effective.
Keywords: Mental health, Bipolar disorders, Schizophrenia, Autism, Survey, Stigma, Discrimination, Attitudes,
Behaviours
Background
Stigmatization of individuals with mental disorders has
been noted throughout history. However, contemporary
research suggests that prejudice and discrimination can
change as a function of general shifts in social attitudes
or specific alterations in mental health literacy about a
disorder and its perceived treatability [1-6]. The varying
impact of these attitudes or understanding over time
may partly explain why studies of public knowledge of
and/or attitudes toward mental disorders produce con-
flicting findings. For example, since the 1950s, stigma
associated with disorders such as depression and
anorexia nervosa appears to have declined, partly be-
cause people are more likely to attribute the causes to
stressful life circumstances, with which they identify
more readily [7,8]. Furthermore, familiarity with these
disorders (either through personal experience or expos-
ure to the illness experiences of family members or
others) has helped reduce social distancing, which in turn
decreases the risk of discriminatory behaviours [9,10].
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In contrast, stigma associated with psychotic disorders
such as schizophrenia may be increasing [3,5,6,9,10].
The reasons are not certain, but it is suggested that un-
favourable stereotypes of individuals with schizophrenia
(depicting their behaviour as unpredictable and violent)
have become more rather than less prevalent. This
public image is associated with fearfulness in the com-
munity, leading to social avoidance and/or negative dis-
crimination [11]. It is also hypothesized that there have
been unexpected negative consequences of promoting
‘biogenic’ aetiological models [12]. Although greater
awareness of the causal role of genetic or biological fac-
tors has decreased attributions about personal responsi-
bility for developing a severe mental disorder, it appears
that biogenic models are more liable to be construed as
meaning the prognosis is poor and treatment less likely
to improve outcomes [13]. However, these data refer to
adults and there is not data regarding views of genetic
risk factors in childhood and whether this would worsen
or improve attitudes towards such individuals [2].
A number of theoretical frameworks have been developed
that explore the above themes, their inter-relationships
and any mediating or moderating factors. According to
Thornicroft et al. [14], ‘stigma’ is an overarching term
that contains three key elements: problems of know-
ledge (ignorance); problems of attitudes (prejudice); and
problems of behaviour (discrimination). This conceptual
approach overlaps with social cognition theories of
stigma, such as Weiner’s Attribution Model [15,16]: a
model describing how cultural stereotypes, attributions
about controllability of and responsibility for illness
onset, and mediating emotional responses (such as
anger or pity), predict the likelihood of helpful or dis-
criminatory behaviours towards individuals with mental
disorders. The majority of studies utilizing these theor-
ies conceptualize ‘mental disorders’ as a single entity or
only focus on schizophrenia [2]. A smaller number of
studies compare public knowledge, attitudes and/or
reactions toward two disorders (usually depression with
schizophrenia), and still fewer contrast depression and
schizophrenia with other diagnostic groups such as sub-
stance misuse disorders or physical disabilities [10].
European (Germany, Italy and the UK), North American
(USA and Canada), Australasian (Australia and New
Zealand) and cross-national (Japanese- Australian)
studies demonstrate that there are shared stereotypes of
psychosis or depression, with many cultural similarities
(but also some differences) in attitudes and attributions,
emotional responses and tolerance (e.g. [17]). In gen-
eral, more anger and overt discrimination is directed at
individuals with disorders such as substance misuse,
purportedly driven by widely held beliefs that the
individuals are ‘blameworthy’ and their behaviours are
‘irresponsible’ e.g. [18].
Despite the above research, there are still significant
gaps in our understanding of stigma and its conse-
quences. For example, few studies specifically examine
mental illnesses with symptoms that span the spectrum
of common and severe mental disorders. Bipolar disor-
ders (manic-depression) are the obvious example of
such an illness, as the individual may present with de-
pression, mania and/or psychotic symptoms at different
time points. However, bipolar disorders are rarely tar-
geted in public stigma research and even fewer studies
have differentiated between perceptions of mania and
depression (an exception is [16]). Another limitation of
current research is that little is known regarding differ-
ences in knowledge and attitudes toward childhood
compared with adult mental disorders. Studies of
stigmatization of children and adolescents have invari-
ably been conducted in isolation from those of adults,
or the research has investigated the experiences of the
parents of children with neuro-developmental disorders
[19,20]. It is unclear whether members of the public are
consistent in their attitudes, emotional responses and
behaviours toward disorders such as autism that com-
mences during childhood, compared with schizophre-
nia, depression and mania that usually commences in
early adulthood.
Our objectives were to:
a) establish the feasibility of using the internet to
recruit a representative sample of adults as a vehicle
to undertake a brief survey of knowledge, attitudes
and beliefs
b)undertake the first French study of knowledge,
attitudes and behaviour towards individuals with
mental disorders
c) compare public perceptions of different sub-types of
mental disorder, namely a specific childhood
developmental disorder (autism), a severe mental
disorder (schizophrenia) and a disorder that
emulates the presentation of both common and
severe mental disorders (bipolar disorders).
Methods
The study was a collaborative project between a multi-
disciplinary academic team and an independent contrac-
tor with experience of market research (Ipsos Public
Affairs). The survey was conducted by Ipsos in accord-
ance with the French laws on privacy. The academic
team advised on questionnaire content, had access to all
the data and takes full responsibility for the integrity of
the analyses and reported research findings. The con-
tractor designed the internet survey instrument, under-
took recruitment, performed data collection and was
responsible for quality assurance.
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Sample
Individuals aged > =18 years, drawn from an established
market research panel available to Ipsos, were con-
tacted via email and invited to complete an online
survey between May 8–12, 2009. In the absence of re-
sponse to the initial contact, individuals were contacted
on one further occasion three days later. Recruitment
continued until 1000 responses were obtained. To try
to ensure the recruited sample was representative of
the general adult population of France, sampling was
stratified initially for place of residence (taking into ac-
count population density) then according to gender,
age (in 5 years groupings) and socio-economic status
(according to occupation of the head of household).
Survey questionnaire
In order to ensure this was a brief, user friendly, inter-
net questionnaire that was acceptable to a target popu-
lation the survey instrument was limited to 21 items
written in French. The final set of questions selected
targeted key domains such as mental health knowledge
(n = 8), attitudes (n = 5) and behaviours (n = 4) towards
those with mental disorders and familiarity with mental
disorders (n = 4). These items were designed to capture
data on key themes examined in previously published
questionnaires exploring knowledge, attitudes and
beliefs [1-3,9,11,18,21-23]. However, the researchers did
not use established questionnaires as (a) using a set of as-
sessment tools for each issue we wished to target would
extend the duration of participation to 30–50 minutes,
which would lead to significant loss of participants on
the internet and was also counter to the idea of a very
brief questionnaire, (b) we especially wanted to explore
views of disorders spanning childhood and adulthood
and different types of presentations and none of the
questionnaires or assessment tools available covered
this range, (c) we wished to explore whether individuals
understand the ‘terminology’ of mental disorders and
what actually constitutes the disorder named eg schizo-
phrenia (ie do people know not just the words or names
used to describe mental disorders such as schizophre-
nia, but can they actually spontaneously describe the
symptoms and problems that are integral to the disorder
with that name), as such we designed some new ques-
tions to look at this, (d) we decided that to make this a
simple user friendly survey the information on names
and symptoms of disorders would be used as an alterna-
tive for case vignettes.
Knowledge items (n = 8) included the following- views
of the likely prevalence of mental disorders in the
general population, causal attributions (eg views of risk
factors such as genetic vulnerability, external stressors, etc.),
beliefs about controllability (by the individual them-
selves or via different treatments), beliefs about stability
and predictability. Attitudes (n = 5) and behavior (n = 4)
were explored by questions that assessed terminology
used to describe mental disorders, and reactions such as
avoidance or social distancing. Familiarity questions
(n = 4) explored issues such as personal or family experi-
ences of mental disorders and predictions about future
vulnerability (factors that may act as modifiers of reac-
tions); these were supplemented by questions that
explored views on likely help-seeking and probability of
self-disclosure.
The item format included ‘yes/no/don’t know’ ques-
tions, rank ordering of statements or Likert scale ratings.
Respondents were also asked to endorse adjectives, verbs
or expressions (from a list provided) that describe
responses to mental disorders in general and then indivi-
duals with mental disorders specifically. The responses
were then further classified qualitatively (eg ‘anger’, ‘pity’,
‘fear’, etc.) to allow the identification of key themes such
as sympathetic, empathic or prejudicial [24]. Likewise
some questions about predicted behaviours (eg would
the respondent be prepared to work alongside someone
with a bipolar disorder, schizophrenia or autism)
assessed differences in reaction to, or degree of discrim-
ination towards each disorder.
Statistical analysis
Data was analyzed using the SAS 9.1 statistical software
package (SAS Corporation, Cary NC). Statistical signifi-
cance was set a priori at the p < 0.05. For ease of inter-
pretation, all data are presented as percentages unless
stated otherwise. Basic statistics, such as chi-squared
and rank order testing, were used to explore any specific
differences regarding level of knowledge about risk fac-
tors for and attitudes towards each of the three disorders
studied and when differences were found we then also
examined whether there was an age group or gender
effect. Missing values were dealt with by excluding a
case with missing values from a specific analysis of that
variable.
Results
Feasibility of conducting a brief internet survey
representative of the French population
The target sample of 1000 respondents was recruited
within the five day time frame. The sample was 52%
female (see Table 1) and the mean age was 45 years
(SD 14), about 30% were aged <35 and a similar
proportion were aged 55–64 years. About 20% had
received tertiary education and the mean monthly
household income was 2,300€. About 18% lived in the
Paris region, 11% in the south west, with the rest of
the sample distributed evenly across the North West,
north east and south east. The sample demographics
are therefore similar to the adult population of France.
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Nine hundred and 16 of the 1000 questionnaires were
fully completed or provided sufficient responses to allow
some or all the questions completed by the individual to
be included in the analyses.
Mental health knowledge
Less than one in five respondents (17%) correctly iden-
tified the estimated prevalence of mental disorders to
be 21-30%. However, there was almost universal recog-
nition of the names of most mental disorders including
the three specific disorders investigated, with 100%
respondents recognizing the term autism and 97% and
96% respectively recognizing the terms schizophrenia
and bipolar disorders. However, when respondents
were asked if they could describe some of the charac-
teristics of these disorders, the proportions decreased
to 67% for autism, 53% for schizophrenia and 43% for
bipolar disorders. Both awareness and knowledge of the
disorders tended to increase with age (up to 55 years)
and socioeconomic status but findings were inconsist-
ent across disorders. When age and social status were
controlled for, women were more frequently aware than
men of mental disorders in general (p < 0.01) and the
specific characteristics (p < 0.05).
As shown in Table 2, views about disorders showed
significant differences (X2= 55.4; df = 8; p < 0.002): views
about the need for treatment (less treatment) and prog-
nosis (better outcome) favoured bipolar disorders;
schizophrenia was regarded as similar to autism in hav-
ing an early onset but viewed as dissimilar in ‘not being
diagnosed early’. When offered a list of possible risk fac-
tors for each disorders, about two thirds of the sample
rated drug or alcohol misuse as the most important risk
factor for schizophrenia, 44% rated genetic factors as
most important for autism, whilst 67% endorsed emo-
tional stress as the most important risk factor for bipolar
disorders; the rank ordering of risk factors for each
disorders was statistically significant (p < 0.001).
Only 33% respondents considered information avail-
able about mental disorders and their treatments to be
adequate, but they rated the media as a more frequent
source of sufficient information (30%) ahead of doctors
(27%) or health professionals (21%) or other public ser-
vices (13%). When asked to rate the effectiveness of a list
of different treatments approaches, a minority (<1 in 5)
of interviewees expected medication or psychotherapies
to be ‘very effective’, whilst >30% considered all treat-
ments to be ineffective or did not know if they were
likely to be beneficial. When controlling for age group,
women were significantly more likely than men to
believe psychological treatments would be very effective
(70% v 58%; p < 0.01) and also more likely to endorse
medications (74% v 66%).
Attitudes & behaviours
When asked to provide descriptors of mental disorders,
61% respondents reported pejorative labels (e.g. 47% used
the words mad or lunatic). Compassionate descriptors,
(e.g. sad or sorrowful), were used by 29% respondents.
In comparison, when respondents were asked to provide
descriptors of individuals with a mental disorder rather
than of mental disorders per se, respondents were more
likely to use compassionate (34%) and less likely to use
negative labels (18%). There was a four-fold likelihood
of respondents being compassionate rather than pejora-
tive if considering individuals rather than disorders
(Odds Ratio 3.97, 95% Confidence Intervals 1.92 to 8.18;
X2= 14.6, df = 1, p < 0.001)
As shown in Figure 1, respondents viewed indivi-
duals with autism or bipolar disorders to be able to
live in society, and viewed individuals with bipolar
disorders as most likely to be able to work- views that
were less likely to be endorsed for schizophrenia. Fa-
miliarity with mental disorders was associated with a
non-significant trend for greater endorsement of the
ability of individuals with autism or bipolar disorders
to live in society, but no increase in rate of endorse-
ment for individuals with schizophrenia.
Table 1 Sociodemographic characteristics of sample
VARIABLE NUMBER(Total = 1000)
Gender Male 481
Female 519
Age in years 18–24 109
25–34 183
35–44 188
45–54 181
55–64 293
>= 65 46
Level of Education None 21
Primary 310
Secondary 412
Tertiary 257
Monthly Income =< 2000 € 275
2000 to 3000 € 391
3000 to 4500 € 209
Over 4500 € 76
Not reported 155
Region of Residence North east 242
North west 238
South east 231
South west 112
Paris & environs 177
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Of the three disorders studied, schizophrenia gener-
ated the greatest fear, distrust and desire for social dis-
tancing: 65% respondents considered individuals with
schizophrenia to be dangerous to others (as shown in
Figure 1, this compares with 29% for bipolar disorders
and 7% for autism; X2= 12.1, df = 2, p < 0.001). Further-
more, 30% would refuse to work with an individual with
schizophrenia (bipolar disorders = 12%, autism=6%;
X2=11.8, df = 2, p < 0.002), 31% would not want their chil-
dren in the same class at school (bipolar disorders = 15%,
autism=3%; X2=21.5, df = 2, p < 0.0002) and 24% would
not agree to live with a relative with schizophrenia
(bipolar disorders = 11%, autism = 6%; X2 = 11.3, df2,
p < 0.003). Figure 1 shows that respondents rated 22%
of individuals with autism as a danger to themselves,
compared with 74% of individuals with schizophrenia and
71% with bipolar disorders (X2=10.3; df = 2; p < 0.004).
Familiarity
Although 40% of respondents reported familiarity with
mental disorders only 5% (n = 55) reported a previous or
current personal history of one or more mental disorder;
an additional 34% did report they knew a friend or rela-
tive with a mental disorder. Of those with a personal
history, 80% (n = 44/55) reported depression or mixed
depression with anxiety, 9% (n = 5/55) bipolar disorders
and 1.8% (n = 1) schizophrenia. A majority of respon-
dents (65%) considered that they were potentially at risk
Table 2 Respondents views about course of mental disorders and risk factors for schizophrenia, bipolar disorders and
autism*
Views about course: Schizophrenia Bipolar disorders Autism Differences between
disorders*
Develops early in life 44% 31% 45% p< 0.002
Early diagnosis is possible 38% 36% 84%
Requires lifelong treatment 74% 53% 61%
With treatment, a person can live a normal life 49% 56% 25%
It will become more severe / worsen over time 42% 37% 21%
Views about risk factors:
Drugs & Alcohol Misuse 58% 54% 3% p< 0.001
Stressful Life Events 52% 67% 23%
Life Style/Environment 42% 64% 11%
Parent-Children Interactions 32% 49% 22%
Genetic Factors 27% 25% 44%
Did Not Know 17% 12% 21%
*see text for details: views about course of disorder show % giving a ‘yes’ response; views about risk factors show % ranking each item first or equal first.
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
Danger to Self Danger to Others Unable to Live in Society Unable to Work
Schizophrenia
Bipolar disorder
Autism
Figure 1 Respondents endorsement of levels of dangerous and social disabilities of individuals with schizophrenia, bipolar disorders
and autism.
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of developing a mental disorder and two thirds also
endorsed the statement that this was also true for mem-
bers of their family. Interestingly, whilst it was unsur-
prising that 61% thought the most likely disorder to be
experienced in the future would be depression, bipolar
disorders (19%) was ranked second, ahead of anxiety
(17%) or any other disorder. However, if problems were
to occur, 30% of respondents stated that they would not
mention it to their relatives, 60% would not mention it
to friends, and 95% would not mention it at their
workplace.
Discussion
These data represent the first population-based survey
of current public awareness, knowledge and attitudes to-
wards mental illness in France.
Main findings of this survey
In a sample of 1,000 French persons, name recognition
for mental disorders was high and marginally greater
than reported in Australia (61%; [12]) and Scotland
(72%; [22]). However, awareness of mental disorders (by
name) was not necessarily accompanied by knowledge
about the characteristics of the specific disorders and
there were also limited expectations, especially in men,
for treatment efficacy. Negative views of schizophrenia
in this sample seem to be similar to those reported in
other studies many decades earlier (eg [16]). Interest-
ingly, prejudice, which was evident from the frequent
use of negative labels about mental disorders in general,
was significantly less overt when descriptors were related
to an individual with a mental disorder. This is a rele-
vant finding when considering how we might attempt to
reduce stigma, but this simple question represents a
novel method of examining this issue.
There were interesting and previously unreported dif-
ferences in public views of risk factors for each disorder
studied, with genetic factors rated as most important in
autism but psychosocial factors predominating in bipolar
disorders and substance misuse more often rated as a
risk factor for schizophrenia. This finding is especially
interesting given the fact that there is increasing concern
that messages regarding the biogenic nature of mental
disorders may have increased rather than decreased
negative views of adult mental disorders- this effect was
not consistently observed in our study as it appeared to
differ across disorders, possibly suggesting that age of
individuals with a disorder may influence levels of
stigma [3,5,6].
The acknowledged personal experience of mental disor-
ders was lower than predicted and this, plus the fact
respondents also stated they would not readily share infor-
mation with friends or work colleagues (and only 1 in 3
stated they would admit such problems to their family),
suggests potentially high levels of self-stigma and fears
about negative judgments or rejection by other people.
Intriguingly, individuals ranked bipolar disorders as
the second most likely future mental health problem
(after depression), ahead of other common mental dis-
orders, perhaps indicating that in the public’s mind
bipolar disorders are more like depression rather than
being severe mental disorders with many similarities
with psychoses.
Specific questions on bipolar disorders, autism and
schizophrenia
The responses to questions focusing on bipolar disor-
ders, autism and schizophrenia showed a marked con-
trast between views of schizophrenia compared with the
other disorders. Individuals with schizophrenia were
considered dangerous by two out of three respondents
and responses indicted that participants continue to
have negative view of this disorder with low expectation
of patient functioning and a desire for social distance
for themselves and their children. Such attitudes were
less likely to be expressed regarding bipolar disorders
and remarkably rare in response to autism. The fact that
negative stereotypes of schizophrenia prevail (despite
research that challenges these notions e.g. [25]), may
indicate that media views of schizophrenia are still a
more powerful influence. Direct support for this hy-
pothesis comes from our finding that this sample
acknowledged the media as their main source of infor-
mation regarding mental disorders. Portrayal by the
media of persons with psychosis as dangerous or help-
less seem to be the norm while images of such people at
school, work or enjoying themselves in the community
are rare or absent [26,27]. Historically, there has been
less media coverage of autism and bipolar disorders; not
only have these disorders only recently begun to attract
more public attention, but so far, the images presented
in the media have tended to be positive rather than
negative and are more often focused on an individual
experiences (eg films such as ‘Rain Man’ or reports of
celebrities with bipolar disorders) or agreement that
there is a need to provide resources to support indivi-
duals (eg special school support for autism).
Study limitations
The company undertaking the majority of opinion sur-
veys in France (Ipsos Public Affairs) provided a sample
of sufficient size to ensure only a 3% margin of error.
However, the survey was conducted online using indivi-
duals already recruited to a panel for market surveys, so
by definition respondents were computer literate and
accessed the internet regularly. Rates of declared per-
sonal history of mental health problems were also lower
than expected. This sample may therefore be more
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homogeneous than in other community studies which
may explain why we failed to find more consistent
socio-demographic trends as reported in some previous
studies [2,23]. The main study limitation is however that
in order to make this a brief, internet based question-
naire we have used the concepts and ideas prevalent in
the literature but did not use a set of previously vali-
dated reliable questionnaires, also some concepts needed
to be translated into French (which in some cases may
change the subtlety of the original meaning eg whether a
person is described as being ‘able to work’ as opposed to
‘unable to work). Hence there may be issues in the na-
ture of the questionnaire that will reduce our ability to
compare some of the findings with other studies. Also
we used diagnostic labels in some instances instead of
case vignettes which will affect the views expressed or
items endorsed [13].
Conclusions
Except for a short media campaign on Depression in 2007
(3 minutes of information broadcasted during prime time
on a national network), France has not undertaken an
anti-stigma campaign such as “Changing in Minds” in UK
(1998–2002),”Beyond Blue” in Australia (2001–2005),
“Like Minds Like Mine “ in New Zealand (1997–2004) ,
the 'See Me' –national campaign in Scotland ( 2002–2004)
or BASTA (Bavarian Anti-Stigma-Action). In eight coun-
tries where such public awareness campaigns took place,
the programs contributed to a modest improvement in
public knowledge of and attitude toward mental disorders
[28]. The current survey demonstrates that if the French
public is to benefit from a similar venture, any campaign
should take into account the fact that (a) as attitudes to-
wards individuals with a disorder are more benign than
those expressed about mental disorders in general, it
would be beneficial to build on approaches that specific-
ally use personal testimonies and raise the visibility of
individuals with mental disorders who are living normal
lives, as this is likely to be more effective than generic
campaigns trying to de-stigmatize the disorders [29] and
(b) the public appear to differentiate between autism
(individuals were not viewed as being personally respon-
sible, nor where they seen as dangerous), bipolar disorders
(viewed differently from severe disorders and rated as
likely to have a good outcome even in the absence of treat-
ment) and schizophrenia (viewed by the majority as likely
to have a poor outcome, potentially dangerous and cannot
live independently or work in the community). The latter
suggest strongly that a campaign that treated mental
disorders as a single entity is unlikely to be successful.
Furthermore, any strategy that does not involve re-
educating the media or fails to gain their support in dis-
seminating a more balanced view is likely to fail. It may be
that a stepped model would be a more helpful strategy,
starting by building upon knowledge and more benign
attitudes regarding depression, introducing information
about bipolar disorders, then gradually making links be-
tween the more severe aspects of this disorder and psych-
oses in general, with a view to identifying similarities
between schizophrenia and highlighting policy initiatives
such as early intervention programmes that have
improved clinical and social outcomes. Such programmes
cannot rely on ‘information’ alone as it is known that
whilst this is important, it is insufficient on its own to
change attitudes and behaviours. So additional strategies
that raise the visibility of individuals with a disorder, rather
than just of the disorder will be important, especially pro-
jects that use an interactive approach to engaging people
in dialogue [30,31]. This survey however confirms that
stigma and prejudice towards schizophrenia is equally
prevalent in France as elsewhere. However, it also demon-
strates that public awareness, knowledge, attitudes and
behaviours towards mental disorders varies between dif-
ferent presentations. Future initiatives to challenge stigma
and discrimination should therefore consider whether
disorder-specific initiatives will be more effective than
general approaches to mental illnesses.
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